Do These 2 Cannabis Stocks Have a Future?

The federal rescheduling of cannabis from Schedule 1 to Schedule 3 should materially ease banking access and allow normal business expense deductions, potentially boosting demand and margins across the U.S. cannabis sector. However, interstate commerce remains prohibited, and the article highlights that Aurora Cannabis lacks U.S. retail/distribution exposure while Canopy Growth faces stiff competition despite its Canopy USA unit; both companies carry weak fundamentals and limited near-term upside, making them unattractive investments in the author's view.

Analysis

Market structure: Rescheduling is a positive shock for U.S. MSOs, banks, and payments/ancillary vendors because it reduces operational frictions (banking, tax deductibility) but it is not full federal legalization — interstate commerce remains banned so scale advantages are state-by-state. Direct losers: Canadian LPs with legacy overcapacity and weak balance sheets (CGC, ACB) — they face continued margin pressure as U.S. entrants and well-capitalized MSOs compete; expect downward price pressure on wholesale cannabis and continued retail price deflation in oversupplied provinces over 12–24 months.

Risk assessment: Tail risks include a legal/administrative challenge that reverses DOJ/Federal guidance or delays bank rule changes (low probability, high impact), and accelerated capital-starvation-driven bankruptcies among small LPs in 6–18 months. Short-term (days–weeks) volatility will spike on news and M&A rumors; medium (3–12 months) risks center on execution and access to U.S. distribution; long-term (2–5 years) depends on federal statutes — only full legalization materially expands interstate economics.

Trade implications: Tactical: bias short CGC and ACB (weak fundamentals, leverage, low cash) and long selective U.S. MSOs with retail footprints and positive EBITDA. Use option hedges: buy 6–12 month put spreads on CGC/ACB to cap capital outlay and sell premium against buying LEAPS calls on TRUL/CRLBF to express U.S. upside. Pair trade: long TRUL (2–3% portfolio) / short CGC (1–2%) to isolate U.S. operational beta vs Canadian structural risk.

Contrarian angles: Consensus overweights regulatory progress and underestimates execution risks — markets may be underpricing consolidation value in U.S. MSOs and overpricing turnaround hopes in Canadian LPs. Historical parallels: state-by-state legalization (sports betting) shows slow revenue accumulation followed by rapid consolidation; a 20–40% re-rating of best-in-class U.S. operators is plausible within 12–24 months if capital markets reopen and M&A picks up. Unintended consequence: easier banking could spur aggressive roll-ups that temporarily inflate supply and compress retail margins, creating entry points on subsequent sell-offs.

Key Decisions for Investors

• Establish a 1.5% portfolio short position in CGC and a 1% short in ACB using 6–12 month put spreads (buy 20% OTM put, sell 10% OTM put) to limit cash outlay; target a 30–50% downside within 12 months, place stop-loss if names rally >25% from entry.
• Allocate 2.5% portfolio long to U.S. MSOs: 1.5% TRUL (Trulieve, NYSE: TRUL) and 1.0% CRLBF (Cresco Labs, OTC: CRLBF). Hold 12–24 months; target 30–40% upside if MSO revenue share in regulated states rises >20% and M&A accelerates.
• Implement a pair trade: long TRUL (1.5%) / short CGC (1.0%) to capture U.S. operational upside vs Canadian structural risk; rebalance if spread narrows by >15% over 3 months or after major legislative events.
• Use options to hedge conviction: buy 9–12 month put spreads on CGC/ACB and fund by selling 12–18 month covered calls or selling premium on overbought MSO names; enter on volatility >40% or after relief rallies (>15% move) to improve pricing.
• Monitor specific catalysts over next 90 days: (1) any Treasury/FDIC bank guidance on cannabis accounts, (2) House/Senate bill progress, (3) quarterly U.S. revenue disclosures — if two of three confirm materially faster U.S. access, increase MSO long weight to 4–5% and reduce Canadian LP shorts by half.